SERVICE: PHD & Post-doc scholars/B2C

SERVICE: Pharma, biotech companies/B2B (eg: biocon, ABLE association)

PRODUCT: 'Feed Supplement' (for aquaculture and poultry, hatcheries, fish farms)

PRODUCT: Bioactive compounds+fmcg ( eg: Q10 toothpaste, Q10 milkymist etc)

Age

23-35

45-60

40-60

45-60

Gender

M & F

80% Male

80% male

CTA

CTAs That Convert:

• “Explore CRISPR kits built for Indian researchers.”
• “Get your first synthetic biology kit—starting at ₹1999.”
• “Download our research-ready guide to CRISPR & BAC.”
• “Join 2000+ young scientists accelerating their research with affordable biotech tools.”
• “Apply for student discounts and get your kit delivered anywhere in India.”

CTAs That Move the Needle:

• “Schedule a private briefing on our CRISPR-enabled CoQ10 platform.”
• “Request technical data and pilot results for precision fermentation strains.”
• “Talk to our scientific co-founder about potential licensing models.”
• “Explore how our proprietary strains can plug into your R&D pipeline.”
• “Let’s co-develop a novel bioactive for your next-gen therapeutic.”

Practical & Low-Commitment

• “Request a free sample pack for farm trials.”
• “See trial results from farms in Andhra & Tamil Nadu.”
• “Book a demo with our feed performance team.”
• “Talk to our nutritionist about customizing a supplement for your birds/fish.”
• “Get our tech sheet with feed conversion and ROI stats.”

Strong CTAs

• “Book a formulation demo with our biotech team.”
• “Request a CoQ10 sample pack + clinical dossier.”
• “Talk to our R&D partner team for exclusive licensing.”

Location

Bangalore, Delhi, TamilNadu

Nationwide ( Bangalore, Hyderabad, Delhi, Tamilnadu )

• Location: Tier 2/3 hubs (Andhra Pradesh, Tamil Nadu, Gujarat, Punjab)

 Tier 1 cities - Hyderabad, bangalore, Delhi, Gujarat

Education Level

PHD

MSC & PHD

MBA's / CEO /Executives

Decision maker

Self ( one level)

MD / R&D head (Find the hippo's) and blockers*

• Decision Makers: Founders, MDs, Farm Directors, Feed Buyers

Find Hippos and blockers.

Income Level

4-5.5L INR- tier 1 and 2-3L INR- tier 2

Turnover 1-2k crores

• Income Level: High-revenue but price-sensitive, family-led businesses

Mostly Publicly listed companies or companies that 'want to go public'- challengers to incumbents.

Jobtype

Self-employed/institute

Csuite Employee

Csuite

Device

Desktop & mobile

Desktop and mobile

mobile & desktop

Mobile and desktop

Apps & devices they use/frequently/websites?

Psychology/motivation

They're looking for personal or academic gain—not buying on behalf of an institution or company.

• Pipeline Advancement
  • Seeking innovative tech (e.g. CRISPR-edited strains, bioactive ingredients like CoQ10) to enhance or expand their drug, supplement, or diagnostic product lines.
• Strategic Differentiation
  • Want to stay ahead of the curve by integrating proprietary or IP-rich biomanufacturing platforms into their R&D or production.
• Efficiency & Cost Advantage
  • Looking for cost-effective, high-yield, or next-gen methods (like CRISPR-based strain optimization or synthetic biology) that reduce COGS or boost scalability.
• Regulatory & Clinical Validation Pathways
  • Interest in partnerships or tools that help streamline regulatory compliance or accelerate clinical development timelines.
• Innovation Signaling
  • Want to be seen as technology-forward, especially to investors, regulators, and the scientific community.

1. Better Growth & Yield

• “Will this improve growth rate, FCR (feed conversion ratio), and survival rate?”

2. Scientific Edge Without Complexity

• They want results, not theory. Bioactive feed sounds good if it’s practical, cost-effective, and improves output.

3. Cost Efficiency

• Feed is a major input cost—they’ll buy if your supplement saves money in the long run (less disease, faster growth).

4. Differentiation + Export Readiness

• Exporters want compliance-friendly, antibiotic-free, growth-boosting additives.

1. Product Innovation = Competitive Edge

They want to launch functional SKUs (like Q10 toothpaste, Q10 milk, Q10 energy chews) that stand out in crowded FMCG markets.

2. Premiumization & Brand Storytelling

They’re looking for hero ingredients with clinical backing and consumer demand—CoQ10 being perfect for performance, beauty, and longevity narratives.

3. Brand Credibility & Public Readiness

As public or pre-IPO companies, they need differentiated IP, science-driven positioning, and functional ingredients to please investors, analysts, and health-savvy consumers.

4. Safety + Regulatory Confidence

They care about compliance, consistency, and safety. A biotech-grade CoQ10 (CRISPR-optimized, high-purity) checks that box better than imported or generically sourced options.

Buying Behavior

Buying Behavior: They often self-fund, especially PhD/post-docs in Tier 2/3 cities or from agrarian backgrounds

• Decision-Making Time: Long cycles (3–9 months), often requires multiple stakeholder approvals.
• Evaluation Process:
  • Scientific validation (papers, pilot data, early trials)
  • Regulatory pathways
  • IP ownership or licensing models
• Risk Management:
  • Preference for proof-of-concept, pilot projects, and non-exclusive licensing before scale.
• Budget Allocation:
  • Tied to strategic business units, innovation budgets, or open innovation partnerships.
• Deal Structures:
  • Often licensing, co-development, or joint venture models, not simple transactions.

Buying Behavior

• Behavior Type: Relationship-driven, demo- and trial-based
• Validation Needs: Pilot runs, word-of-mouth, testimonials from known farms
• Risk Appetite: Cautious but will try if it’s backed by results and priced right
• Sales Cycle: Medium (30–90 days), often requires face-to-face pitch

• Evaluation Window: Medium-to-long (3–6 months), but faster if they see a consumer angle or a “functional boost” opportunity.
• Decision Drivers:
• • Clinical validation + purity + price
  • Scale readiness (can you deliver bulk?)
  • Brand leverage: Will this make their product more sellable or media-worthy?
• Blockers:
• • Procurement teams focusing on cost
  • Regulatory/legal bottlenecks
  • Lack of in-house scientific validation or hesitance to take ingredient risks

Family

Agrarian family backgrounds

Messaging***

Tactical Messaging for Conversions

• “Starter CRISPR Kits at ₹1999. Free shipping for students.”
• “Join 2,000+ Indian researchers using our tools.”
• “Certifications & guides included—perfect for your thesis or project.”
• “Get early access to our fermentation starter kits. Limited quantities!”

Messaging to Use with This Persona:

• “De-risk your pipeline with CRISPR-optimized strains.”
• “Scale functional ingredients like CoQ10 with precision fermentation.”
• “Integrate our synthetic biology platform into your drug discovery or supplement line.”
• “Let's co-develop a biomanufactured solution tailored to your therapeutic focus.”

Messaging Themes That Work

Science-Backed Differentiation

“Turn your next product launch into a clinical story. Our CRISPR-optimized CoQ10 delivers bioavailability, purity, and a powerful consumer hook.”

Regulatory-Ready, Scale-Ready

“Biotech-grade CoQ10 designed for food and personal care—GMP-compliant, lab-tested, and ready to scale.”

Brand Leverage

“Move faster than legacy brands. Launch bioactive-enhanced SKUs that appeal to wellness-conscious, science-driven consumers.”

Investor Signal

“Stand out with scientifically differentiated products. Our bioactives help challenger brands look public-ready.”

Customization & Co-Creation

“Let’s co-develop your functional SKUs. From R&D to GTM, we support your science story.”

Criteria

Adoption Rate

​

Appetite to Pay

Frequency of Use Case

​

​

Distribution Potential

ICP 1

High

low-moderate

Moderate

Moderate-High

ICP 2

Moderate

High

Low-Moderate

Low-Moderate

ICP3

Moderate-high

Moderate

High

High

ICP4

High

High

High

High